ehealth radio network
Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?

Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?

August 5, 2015


Josh Hexter, Chief Operating Officer of Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems including what would be the first oral formulation of insulin joins eHealth Radio and the Diabetes, Pharmaceutical, & Health News Channels.


Listen to interview with host Eric Michaels and guest Josh Hexter discuss the following:

  • Many listeners may be familiar with diabetes, either they are affected or know a family member affected by the condition. Can you explain to our listeners the differences between the Type I and II diabetes? What toll does this disease create?
  • What role does insulin play in diabetes? 
  • Why has it taken so long for researchers to turn insulin into a pill? What has been the challenges? 
  • Your company is working on an oral version of insulin. Can you describe how does it work and what stage are you in drug’s development? 
  • Can you explain why treating patients who may be at risk for Type II diabetes (prediabetes) with Oramed’s oral pill? What protection does the oral version of insulin provide?


Duration: 14:35


Mr. Hexter serves as Chief Operating Officer and Vice President of Business Development of Oramed Pharmaceuticals, which he joined in 2013. He brings to Oramed more than 15 years of prominent leadership, business development, operations know-how and management in the life science sector. He was most recently Executive Director of Corporate In-Licensing at BioLineRx Prior to joining BioLineRx, he worked in private equity and venture capital where he served as CEO of a VC-backed startup.


As CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging business development agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security. Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.



Website: www.oramed.com

Glucose Health Assists Type 2 Diabetes Patients in New Product Category

Glucose Health Assists Type 2 Diabetes Patients in New Product Category

June 30, 2015


Kelly Coughlin, the Corporate Spokeswoman and PR Advisor to Glucose Health, Inc. that helps keep your blood sugar balanced joins eHealth Radio and the Diabetes, Health News & Supplement Channels.


Listen to interview with host Eric Michaels & guest Kelly Coughlin discuss the following:

  • What is Glucose Health and why is it an important component of combating Type 2 diabetes?
  • What are the active ingredients in the product?
  • Who developed the formula for Glucose Health?
  • Why is this product different from others on the market?
  • Type 2 diabetes is becoming an epidemic in the U.S.; can Glucose Health help lower the number of affected Americans?
  • Share with us if you would success stories of people using this product.
  • When will Glucose Health be available to consumers in mass market?
  • Where can consumers purchase the product now?


Duration: 9:55


The Centers for Disease Control and Prevention estimates two in five Americans will develop Type 2 diabetes in their lifetime. Addressing the key lifestyle factors that lead to Type 2 diabetes today, will keep you healthy in the future!  Make Glucose Health® a part of your commitment to healthy living.  Certain clinical studies indicate the 6 key natural ingredients in the Glucose Health® formula have important relationships to glucose, insulin, triglycerides and HDL ("good" cholesterol).


Kelly Coughlin is President of Annex Communication. For a decade and a half, Kelly Coughlin has worked as a publicist and strategist between the CPG/retail, healthcare, real estate, media, and sports & entertainment industries.


Her experience includes: building national advertising and public relations platforms, negotiation and creation of national media and sports/entertainment sponsorships, creation of Interactive platforms supported by SEO/SEM practices, and high-profile individual management. Ms. Coughlin has represented entertainers, athletes, physicians, Fortune 500 executives, national brands, sports organizations, festivals and tours, real estate companies and retailers.

Ms. Coughlin holds a B.A. in Communication from Boston College.




Website
: www.glucosehealth.com

New Advances in Diabetes Treatment: Insulin-Producing Cells That Could Replace Injections

New Advances in Diabetes Treatment: Insulin-Producing Cells That Could Replace Injections

May 20, 2015


Dr. Gerald Crabtree, Chief Operating Officer and Director at PharmaCyte Biotechnology, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box joins eHealth Radio and the Diabetes and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Gerald Crabtree discuss the following:

  • In an effort to understand how the Melligen cells works, can you explain what happens to the pancreas in Type 1 diabetes?
  • Why are liver cells such good candidates to replace the damaged cells in the pancreas?
  • What have early lab trials shown?
  • How does PharmaCyte’s Cell-in-the-Box help the melligen cells do their jobs?
  • How will this technology help the lives of those patients living with Type 1 Diabetes?


Duration: 15:55


Dr. Gerald Crabtree is PharmaCyte’s Chief Operating Officer. Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles and served as project manager for development of major oncologic agents. He is a Member of the American Society of Clinical Oncology and also is a past member of research grant review committees for the National Institute of Health and the American Cancer Society. Dr. Crabtree established and directed, from inception, a department that monitored and coordinated the development of oncologic and immunologic drugs from initial discovery through regulatory approval in a major pharmaceutical company and served as project manager for the development of the anticancer agent, Taxol®.


Dr. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada and has published over 80 articles in peer-reviewed journals. He is a National Cancer Institute of Canada Research Fellow. In addition, he served as Department Head of Molecular Pharmacology for the Nucleic Acid Research Institute, and prior to that as Associate Professor of Medicine with the Roger Williams Cancer Center at Brown University. Dr. Crabtree has also served as Director of Project Planning and Management (Oncology/Immunology) at Bristol-Myers Squibb and as Vice-President of Research and Development at ETEX Corporation.



Website: www.pharmacytebiotech.com

Eat Chew Live, offering a revolutionary way of preventing, and even reversing diabetes

Eat Chew Live, offering a revolutionary way of preventing, and even reversing diabetes

April 4, 2015


Dr. John Poothullil, Author of Eat Chew Live, a new book that offers a revolutionary way of preventing, and even reversing diabetes joins eHealth Radio and the Diabetes and Health News Channels.


Listen to interview with host Eric Michaels & guest Dr. John Poothullil discuss the following:

  • What is different or new in your book that others have not already said about diabetes?
  • What is your theory about the cause of diabetes?
  • It is believed that diabetes can be controlled, but you suggest that it can be reversed, tell us how?
  • Your book says, “How you eat is more important than what you eat.” What does this mean?
  • Experts say that eating whole grain foods is beneficial because they contain vitamins. Your book doesn't seem to support that claim. Why?


Tip: The one thing you can do on a daily basis to prevent diabetes is to listen to your body and to be fully present while you are eating, so your body can tell you what it needs to prevent overeating, habitual eating, stress eating, and other behaviors that don't serve our health.


John Poothullill, MD, FRCP practiced medicine as a pediatrician and allergist for more than 30 years. He holds certifications from the American Board of Pediatrics, The American Board of Allergy & Immunology, and the Canadian Board of Pediatrics.


Dr. Poothullil has written articles on hunger and satiation, weight loss, diabetes, and the senses of taste and smell. He has been published in medical journals such as Physiology and Behavior, Neuroscience and Biobehavioral Reviews, Journal of Women’s Health, Journal of Applied Research, Nutrition, and Nutritional Neuroscience. His work has been quoted in Woman’s Day, Fitness, Red Book and Woman’s World.


Dr. Poothullil resides in Portland, OR.



Website: www.eatchewlive.com

Journey to a Miracle: Freedom from Insulin

Journey to a Miracle: Freedom from Insulin

February 25, 2015


Laurie Jaffe with her husband Mike are the driving force behind a new documentary Journey to a Miracle: Freedom of Insulin joins eHealth Radio and the Diabetes and Health News Channels.


Listen to interview with host Eric Michaels and guest Laurie Jaffe discuss the following:

  • What is monogenic diabetes? How does it differ from type 1?
  • How is it tested and should anyone with diabetes be tested?  What is the process?
  • Why do you think there is such a large amount of people that are unaware?
  • What are the obstacles those with type 1 might face?  And what are the Solutions?
  • What is your message in producing and releasing the documentary Journey to a Miracle: Freedom of Insulin


Duration: 16:15


Laurie Jaffe and her husband Mike are the driving force behind a new documentary Journey to a Miracle: Freedom of Insulin. They were inspired to produce the film after their daughter Lilly, who was diagnosed with diabetes at one month old, was able to disconnect her insulin pump for good at age 6 after doctors discovered that she did not actually have type-1 diabetes.


In 2006, Mike attended a JDRF meeting where Dr. Louis Philipson of the University of Chicago Kovler Diabetes Center spoke of an upcoming study in the New England Journal of Medicine involving children diagnosed with diabetes as babies. Dr. Philipson explained that most of the children did not actually have type 1 diabetes, but rather a newly understood genetic form called monogenic that is best treated with oral medication, not insulin shots. The rest is history. The Jaffes made a forever friend in Dr. Philipson who became Lilly’s doctor and helped her transition from insulin to oral medication at the University of Chicago.


Moved by their family’s miracle and the potential of reaching thousands more, the Jaffes felt passionate about helping to raise global awareness of monogenic diabetes. They initiated monogenicdiabetes.org, an authoritative website now administered by the Kovler Diabetes Center. Laurie also began and moderated an on-line discussion/support group for parents whose children were also able to switch their treatment from insulin shots to oral medication. The close-knit group grew as parents contacted Laurie after hearing about their family’s story. The group eventually met in person in 2010 and 2013 at “Celebrating the Miracles” conferences hosted by the Kovler Diabetes Center to bring scientists and families together. Laurie is a founding Leadership Board member of the University of Chicago Kovler Diabetes Center.


Websitewww.journeytoamiraclemovie.com
Facebook: facebook.com/journeytoamiracle

How diabetic families of can encourage healthy weight loss

How diabetic families of can encourage healthy weight loss

October 26, 2014


Dr. Lorraine Platka-Bird, Dietician at Center for Hope of the Sierras, a specialized eating disorder treatment facility in Reno, Nevada joins eHealth Radio and the Diabetes and Eating Disorder Channels.


Listen to interview with host Eric Michaels & guest Dr. Lorraine Platka-Bird discuss the following:

  • I’ve heard about anorexia and bulimia, but what is Diabulimia?
  • What are the symptoms of Diabulimia?
  • How can diabetics find a healthy weight without dangerously altering their insulin levels?
  • How can diabetics learn what insulin level is best for them?
  • Eating disorders are often thought of as being entirely controlled and self-inflicted, are people sick with an eating disorder really in control?
  • Since there is such an overlap between the physical and psychological aspects, what kind of facility should someone with Diabulimia be treated at?


Duration: 9:51


Dr. Lorraine Platka-Bird has been counseling individuals with eating disorders for more than 25 years. She takes a holistic approach to treatment, considering all aspects of physical, mental, social, emotional, and spiritual well-being. In addition to helping clients develop a healthy relationship with food, Dr. Platka-Bird helps individuals minimize eating disorder thoughts and behaviors, improve self-image and self-esteem, and develop healthy coping skills and life skills to improve overall quality of life.



Links:
Website: www.centerforhopeofthesierras.crchealth.com
Facebook: www.facebook.com/centerforhopeofthesierrasfan
Twitter: @Centerforhope

If I Kiss You, Will I Get Diabetes with diabetes advocate Quinn Nystrom

If I Kiss You, Will I Get Diabetes with diabetes advocate Quinn Nystrom

May 7, 2014


Quinn Nystrom, diabetes advocate and author of “If I Kiss You, Will I Get Diabetes” joins eHealth Radio and the Diabetes and Health News Channels. Her company, Qspeak, allows her to advocate, consult and raise funds for diabetes research.


playpodcast.png


Listen to interview with host Eric Michaels & guest Quinn Nystrom discuss the following:

  • What are the biggest misconceptions about diabetes?
  • What have you learned from living with diabetes?
  • What motivated you to write this book, "If I Kiss You, Will I Get Diabetes?"
  • You've been publicly vocal about Joan River's recent comments about diabetes. As she stated, "Get fat. Get diabetes. Die. Lose your fingers." What upset you the most about this? 
  • What do you hope people will walk away with after hearing you speak or reading your book?

Duration: 14:19


Quinn Nystrom is one of those unique individuals that commands a presence.  Whether she’s speaking to an audience of teenagers or adults, Nystrom can relate to both and with the launch of her new book, IF I KISS YOU, WILL I GET DIABETES? for River Place Press, you’ll be hearing her name a lot.


Inspired by her teenage self, the book is Nystrom’s first-hand account of negotiating life with a chronic illness and she now devotes her full-time efforts to diabetes advocacy and has been recognized nationally for her contributions.


For the past 17 years, she has been sharing her story of living with type-1 diabetes to audiences across the country. As the National Youth Advocate for the American Diabetes Association (ADA) she spent a year traveling to diabetes camps, convention halls, the White House, corporate offices and the United States Congress. Her message was simple: Find a cure for diabetes and provide support and care for the millions of people living with the disease.


Nystrom grew up in Brainerd, Minnesota with her younger brother Will who was diagnosed with Type 1 diabetes when he was five years old. By age ten, she was fundraising and going door to door in her small town to raise money for a cure for her baby brother’s disease. However, three years later, Nystrom was diagnosed with Type 1 and her goal to finding a cure became a lifelong mission. She was named the National Youth Advocate for the American Diabetes Association (ADA) at age sixteen and spent a year traveling across the country. Her message was simple; find a cure for diabetes and support the millions of Americans living with it.


Currently a graduate student at Syracuse University in Communication's Management, Nystrom attends S.I. Newhouse School of Public Communications, ranked #1 in the country with alums such as Bob Costas and Dick Clark. As a public speaker she travels across the country to diabetes camps, convention halls, corporate offices, United States Congress and yes, The White House. Her company, Qspeak, allows her to advocate, consult and raise funds for diabetes. A portion of the books proceeds goes to the non-profit she founded called Dateline Diabetes, whose mission is to provide support for people living with diabetes.


Nystrom currently lives in Minneapolis where she enjoys skating on the lakes, making her monthly dinner club with childhood friends, and volunteering at her local church.



Web Site: quinnnystrom.com
Facebook: facebook.com/QuinnNystrom
Twitter: @quinnnystrom


ActiveCare, a real-time patient monitoring company

ActiveCare, a real-time patient monitoring company

August 9, 2013
ActiveCare.png

Michael Jones, an executive with ActiveCare a Utah based, real-time patient monitoring company joins eHealth Radio and the Health Care and Technology Channels.  Jones is an expert in the medical monitoring field, especially as it relates to monitoring the Type 2 diabetic population here in America.


playpodcast.png


Listen to interview with host Eric Michaels & guest Michael Jones discuss the following:

  • What is the primary focus of your company, ActiveCare?
  • Please speak on how ActiveCare improves the quality of life of its members.
  • When we think diabetes, especially Type 2 diabetes, many look down on the sufferers saying, “It’s an eating issue, or a self-inflicted health issue.” What can a person do to overcome this stigma?
  • Have you seen an increase in diabetics drawn to your service to improve their quality of life?
  • What advice can you offer a Type 2 diabetes patient who’s looking for a positive change in handling their disease?

Duration: 13:35


Michael has been a founder and executive in several of the technology industry’s fastest growing companies. Mr. Jones founded Interactive Care in 2007, filing several patents in the field of video collaboration as a tool for delivery of medical care. As Executive Vice President at RemedyMD, Michael led in the advancement of medical collaboration and the utilization of informatics technologies for the treatment of obesity and diabetes.


While Executive Vice President of Sales and Marketing at iBahn (formerly STSN), the company was recognized in consecutive years by Deloitte & Touche and Inc. Magazine for its explosive growth, expanding from $29M to over $120M in annual sales over a three-year period.


Prior to iBahn, Mr. Jones led numerous sales and operations organizations at Iomega Corporation during a period of unprecedented growth, exponentially expanding its distribution, customer support, production and logistics capacities. Michael has also led in domestic and international senior sales leadership roles at Siebel Systems, Silicon Graphics and Oracle. A published author and contributor to periodicals and industry publications, Michael graduated from the University of Utah with a degree in English.


ActiveCarelogo.jpg
Links: www.activecare.com

The need for more effective diabetes education with Martha McHenry

The need for more effective diabetes education with Martha McHenry

October 19, 2012

MMHeadshot_July2009_small.jpg


Martha McHenry a Certified Diabetes Educator and a Managing Partner at Professional Nutrition Therapists to help us with the need for more effective diabetes education to address the diabetes epidemic joins eHealth Radio and the Diabetes Information Channel.


Listen to interview [audio player below] with host Eric Michaels & guest Martha McHenry discuss the following:

  • Why do you think this need exists?
  • How can you reach all these people?
  • Can you give (us) an example of this creativity?
  • Can anyone get access to your online program?
  • What do you hope to accomplish by giving access to more people?


eHealth_PNG_150_2.jpg


Martha McHenry is a Certified Diabetes Educator and a Managing Partner at Professional Nutrition Therapists.  PNT is a national network of Registered Dietitians that deliver nutrition solutions to individuals, groups and corporation across the 50 states.  She is a member of the Academy of Nutrition and Dietetics and is past president of Dallas Dietetic Association where today she sits on the board.


Martha has worked in community nutrition with a special focus on weight management and diabetes care. She co-founded the first community-based diabetes education program in south-west Dallas.


In her capacity at PNT, Martha is responsible for managing diabetes care services at PNT and also for developing new delivery systems of the highly acclaimed DAWN Program, the Diabetes, Awareness, Wellness and Nutrition Program developed at PNT.


PNT-Logo12.png


Related Web Site: www.foodtherapyrd.com


Diagnosis, treat and manage diabetes with NeuroMetrix

Diagnosis, treat and manage diabetes with NeuroMetrix

October 13, 2012

KennethSnow.png


Dr. Kenneth J. Snow, the Chief Medical Officer of NeuroMetrix that develops and markets devices for the diagnosis, treatment and management of diabetes joins eHealth Radio and the Diabetes Information Channel. Dr. Snow has extensive experience in diabetes, including patient care and clinical research.


Listen to interview [audio player below] with host Eric Michaels & guest Dr. Kenneth Snow discuss the following:

  • Tell me about diabetes and its impact on those who have the disease.
  • How prevalent is the disease in the U.S.?
  • What led you to dedicate yourself to diabetes?
  • What unique solutions do NeuroMetrix products provide?
  • What NeuroMetrix products are on the market now?
  • What tip would you give to those who suffer from diabetes? What can patients do to improve their quality of life?


eHealth_PNG_150_2.jpg


Kenneth J. Snow, M.D. is Chief Medical Officer of NeuroMetrix (Nasdaq: NURO).


NeuroMetrix, headquartered in Waltham, MA, develops and markets home use and point-of-care devices medical devices, associated consumables, and support software for the treatment and management of diabetes and its complications. The company is focused on nerve related complications of diabetes, called diabetic neuropathies, which affect over 50% of people with diabetes.


The company markets the NC-stat® DPNCheck™ testing device for diabetic neuropathy. This product is used to detect diabetic neuropathy at an early stage and to guide treatment. The company is in late stage development of SENSUS™, a pain management device which recently received Food and Drug Administration clearance. The company has additional therapeutic products in its pipeline.


Dr. Snow has spent the past 17 years at the Joslin Diabetes Center in Boston, MA. The Joslin Diabetes Center is affiliated with Harvard Medical School and is the world's oldest and most respected diabetes care facility. Most recently, Dr. Snow was Director of Medical Programs at the Joslin Center for Strategic Initiatives. Prior to that he was Acting Chief of the Adult Diabetes Section at the Joslin. Dr. Snow also holds an appointment as Assistant Professor of Medicine at Harvard Medical School.


Dr. Snow has a B.S. in Chemistry from the Massachusetts Institute of Technology, and an M.D. from Johns Hopkins School of Medicine. He completed his internship and residency at Northwestern Memorial Hospitals, Chicago, IL and fellowship training in Endocrinology at New England Medical Center Hospitals, Boston, MA. In addition to his medical training, Dr. Snow has an MBA from the Isenberg School of Business at the University of Massachusetts, Amherst.


NeuroMetrix-Logo.jpg


Related Web Site: www.neurometrix.com


Podbean App

Play this podcast on Podbean App